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Ovarian cancer is predominantly diagnosed at a late stage
due to a relative lack of symptoms in the early stages of
disease. The published screening trials have not demon-
strated any benefit to screening for disease. However,
with relatively widespread use of pelvic ultrasound for
abdominal or pelvic symptoms, adnexal masses are com-
monly identified. The majority of such adnexal masses
are benign and the majority can be readily triaged into
benign or malignant categories using standardized sys-
tems, such as the IOTA simple rules. However, a number
of cases are difficult to categorise and remain indetermi-
nate on ultrasound. It is important to categorise each
lesion as accurately as possible to direct the appropriate
management, ensuring cytoreductive surgery in cases
that are highly likely to be cancer whilst allowing a more
conservative approach in benign cases, particularly when
fertility preservation is of concern to the patient. There is
a body of evidence now to support the role of MRI in the
assessment of this cohort of “difficult to classify” adnexal
masses. The T2 signal intensity characteristics and the
presence of enhancement are important classifiers. Very
low T2 signal intensity and lack of enhancement are mar-
kers of benignity. More recently, the role of diffusion
weighted imaging (DWI) and dynamic contrast enhance-
ment (DCE) has been closely evaluated. The enhance-
ment curves generated from DCE can be a strong pointer
to benignity or malignancy, using the myometrial
enhancement as an internal comparator. Where the solid
component enhances more rapidly and more intensely
than the myometrium, invasive malignancy is highly
likely. In lesions that retain no high signal intensity on
the high b value DWI, benignity is highly likely. A pro-
posed scoring system, the AdnexMR score, has been
developed and is currently being prospectively tested
throughout Europe and several centres in the United
States. This workshop will review the key features for
characterizing adnexal masses, review the proposed
scoring system, and give practice examples for scoring by
the audience.
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